Article
How Biogen Fumbled Aduhelm, Its Once-Promising Alzheimer's Drug
Rating:
0.0
Views:
24
Likes:
1
Library:
1
Early results were so impressive the company raced toward regulatory approval. But its decision to stop trials produced a therapy without proven efficacy that many patients aren't taking; “potentially the worst drug launch of all time.”
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value